Showing results (311-320 of 320) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
Journal of Molecular and Cellular Cardiology|January 6, 2026
Atrial t-tubules adopt a distinct developmental state as Ca2+ handling matures postnatallyC E R Smith, C J Quinn, J D Clarke, et al.
Circulation Research|May 26, 2026
Targeting Arrhythmogenic Late Sodium Current by FHF1A-Derivative FixR in Heart Failure CardiomyocytesBence Hegyi, Paweorn Angsutararux, Nourdine Chakouri, et al.
Circulation Research|August 14, 2024
Restoring Atrial T-Tubules Augments Systolic Ca Upon Recovery From Heart FailureJessica L Caldwell, Jessica D Clarke, Charlotte E R Smith, et al.
Scientific Reports|May 3, 2019
Phosphodiesterase 5 inhibition improves contractile function and restores transverse tubule loss and catecholamine responsiveness in heart failureMichael Lawless, Jessica L Caldwell, Emma J Radcliffe, et al.
JCO Precision Oncology|November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK AlterationsKatherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
AJNR. American Journal of Neuroradiology|November 20, 2020
Recent Administration of Iodinated Contrast Renders Core Infarct Estimation Inaccurate Using RAPID SoftwareA Z Copelan, E R Smith, G T Drocton, et al.
The Journal of Physiology|January 28, 2026
Translating cardiovascular ion channel and Ca2+ signalling mechanisms into therapeutic insightsSilvia Marchianò, Miguel Martín-Aragón Baudel, Charlotte E R Smith, et al.
West African Journal of Medicine|July 14, 2024
Unmet Surgical Need among Adults in A Mixed Urban-Rural Community in Nigeria: A Survey of 1,993 Adults Using the Sosas Survey ToolO B Bankole, A Makanjuola, E O Alabi, et al.
Frontiers in Immunology|November 29, 2023
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responsesKatherine E R Smith, Kah-Whye Peng, Jose S Pulido, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesotheliomaAaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
Pageof 32